Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis

T Crotti, MD Smith, R Hirsch… - Journal of …, 2003 - Wiley Online Library
Objectives and background: This study investigated the expression of key mediators that
regulate differentiation of osteoclasts, receptor activator of nuclear factor κB ligand (RANKL), …

[HTML][HTML] Suppl 1: the normal synovium

MD Smith - The open rheumatology journal, 2011 - ncbi.nlm.nih.gov
This paper describes the structure and function of the normal synovium including the cellular
content, nerve and vascular supply and how normal synovium maintains homeostasis …

Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints

MD Smith, E Barg, H Weedon, V Papengelis… - Annals of the …, 2003 - ard.bmj.com
Background: Synovial biopsies are used to study synovial immunopathology and are increasingly
applied for the evaluation of new therapeutic strategies in chronic arthritis. Therefore, it …

The Jak-STAT pathway in rheumatoid arthritis.

JG Walker, MD Smith - The Journal of rheumatology, 2005 - jrheum.org
The advent of biologic agents targeted against tumor necrosis factor-α (TNF-α) and interleukin
1 (IL-1) receptor has successfully suppressed inflammation in many individuals with …

Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis

…, PJ Roberts-Thomson, MD Smith - Annals of the …, 2006 - ard.bmj.com
Background: Modulation of Jak-STAT signalling may provide an effective therapeutic
strategy in inflammatory arthritis. Objective: To document Jak-STAT expression in a cohort of …

Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction

…, H Weedon, ST Milliken, PP Tak, MD Smith… - Arthritis & …, 2007 - Wiley Online Library
Objective The transforming growth factor β superfamily member macrophage inhibitory cytokine
1 (MIC‐1) is expressed upon macrophage activation, regulated by the p53 pathway, and …

[HTML][HTML] The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)

MC Kraan, DD Patel, JJ Haringman, MD Smith… - Arthritis Research & …, 2000 - Springer
Paired synovial tissue samples were obtained from both clinically uninvolved (CU) and clinically
involved (CI) knee joints of eight rheumatoid arthritis (RA) patients. In addition, biopsies …

[HTML][HTML] Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression

…, F Humby, SM Proudman, C Pitzalis, MD Smith… - PloS one, 2018 - journals.plos.org
Immune checkpoint blockade with therapeutic anti-cytotoxic T lymphocyte-associated
antigen (CTLA)-4 (Ipilimumab) and anti-programmed death (PD)-1 (Nivolumab and …

Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations

…, H Weedon, C Metz, R Bucala, MD Smith - …, 2002 - academic.oup.com
Objective. Cytokines play an important role in the pathology of rheumatoid arthritis (RA).
Macrophage migration inhibitory factor (MIF) is a cytokine with a broad spectrum of actions, …

[HTML][HTML] Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus …

…, A Walsh, X Yin, MD Wechalekar, MD Smith… - Arthritis research & …, 2018 - Springer
Background Plasmablasts and plasma cells play a key role in many autoimmune diseases,
such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This study was …